Nucleus Genomics raised $14M in a Series A led by Founders Fund to advance its genetic testing technology.
Amount Raised
$14 Million
Round Type
Series A
New YorkOtherBiotechnologySoftwareHealth CareInvestors
Description
Nucleus Genomics has successfully secured $14 million in a Series A funding round. This investment, supported by notable investors including Alexis Ohanian's Seven Seven Six, will help the company enhance its genetic testing services.
Quick answer
Nucleus Genomics raised $14 Million in a Series A round, dated January 30, 2025. Investors: Alexis Ohanian’s Seven Seven Six, Balaji Srinivasan, Achal Upadhyaya and Founders Fund. Nucleus Genomics is based in New York, New York, United States.
- How much did Nucleus Genomics raise?
- Nucleus Genomics raised $14 Million in a Series A round on January 30, 2025.
- Who invested in Nucleus Genomics?
- Alexis Ohanian’s Seven Seven Six, Balaji Srinivasan, Achal Upadhyaya and Founders Fund are named as investors in this round.
- What does Nucleus Genomics do?
- Nucleus is an advanced DNA health test that takes the guesswork out of healthcare, whether it’s knowing your risk for cancer or planning for a healthy family.
- Where is Nucleus Genomics based and how big is it?
- Nucleus Genomics is based in New York, New York, United States. Fundz records about 31 employees.
- Who are the decision-makers at Nucleus Genomics?
- Fundz holds 1 contact at Nucleus Genomics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Nucleus Genomics, and when
A new round usually means Nucleus Genomics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Nucleus Genomics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nucleus Genomics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nucleus Genomics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nucleus Genomics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansNucleus Genomics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.